Short-term Effects of Online Hemodiafiltration on Phosphate Control: A Result From the Randomized Controlled Convective Transport Study (CONTRAST)

American Journal of Kidney Diseases

Volumn 55, Issue 1, 2010, Pages 77-87

  Penne, E Lars ^a,b   van der Weerd, Neelke C ^a,b   van den Dorpel, Marinus A ^c   Grooteman, Muriel P C ^b   Lévesque, Renée ^d   Nubé, Menso J ^b   Bots, Michiel L ^a   Blankestijn, Peter J ^a   ter Wee, Piet M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Maasstad Hospital Rotterdam   (Netherlands)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Convective clearance; hemodiafiltration; hemodialysis; nutrition; phosphate; phosphate binding agents; residual renal function; treatment targets

Indexed keywords

PHOSPHATE; PHOSPHATE BINDING AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL;

EID: 71849119771     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.09.023     Document Type: Article

References (40)

1. Block G.A., Klassen P.S., Lazarus J.M., Ofsthun N., Lowrie E.G., and Chertow G.M. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15 8 (2004) 2208-2218
2. Young E.W., Akiba T., Albert J.M., et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44 5 suppl 2 (2004) S34-S38
3. Block G.A., Hulbert-Shearon T.E., Levin N.W., and Port F.K. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 4 (1998) 607-617
4. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70 4 (2006) 771-780
5. Melamed M.L., Eustace J.A., Plantinga L., et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70 2 (2006) 351-357
6. Slinin Y., Foley R.N., and Collins A.J. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS Waves 1, 3, and 4 Study. J Am Soc Nephrol 16 6 (2005) 1788-1793
7. Raggi P., Boulay A., Chasan-Taber S., et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol 39 4 (2002) 695-701
8. Tentori F., Blayney M.J., Albert J.M., et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52 3 (2008) 519-530
9. Punal J., Lema L.V., Sanhez-Guisande D., and Ruano-Ravina A. Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: a systematic review. Nephrol Dial Transplant 23 8 (2008) 2634-2646
10. Suri R.S., Nesrallah G.E., Mainra R., et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 1 1 (2006) 33-42
11. Walsh M., Culleton B., Tonelli M., and Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67 4 (2005) 1500-1508
12. Culleton B.F., Walsh M., Klarenbach S.W., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298 11 (2007) 1291-1299
13. Ayus J.C., Achinger S.G., Mizani M.R., et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int 71 4 (2007) 336-342
14. Minutolo R., Bellizzi V., Cioffi M., et al. Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. J Am Soc Nephrol 13 4 (2002) 1046-1054
15. Zehnder C., Gutzwiller J.P., and Renggli K. Hemodiafiltration-a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 52 3 (1999) 152-159
16. Lornoy W., De M.J., Becaus I., Billiouw J.M., Van Malderen P.A., and Van P.M. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients. J Ren Nutr 16 1 (2006) 47-53
17. Zucchelli P., and Santoro A. Inorganic phosphate removal during different dialytic procedures. Int J Artif Organs 10 3 (1987) 173-178
18. Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 12 1 (2007) 26-33
19. Vaslaki L., Major L., Berta K., et al. On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 24 2 (2006) 163-173
20. Ward R.A., Schmidt B., Hullin J., Hillebrand G.F., and Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11 12 (2000) 2344-2350
21. Wizemann V., Lotz C., Techert F., and Uthoff S. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 15 suppl 1 (2000) S43-S48
22. Penne E.L., Blankestijn P.J., Bots M.L., et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients-the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]. Curr Control Trials Cardiovasc Med 6 1 (2005) 8
23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42 4 suppl 3 (2003) S1-S201
24. Ledebo I., and Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organs 23 1 (1999) 37-43
25. Fouque D., Vennegoor M., ter Wee P., et al. EBPG guideline on nutrition. Nephrol Dial Transplant 22 suppl 2 (2007) ii45-ii87
26. Daugirdas J.T. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 4 5 (1993) 1205-1213
27. Depner T.A., and Daugirdas J.T. Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics. J Am Soc Nephrol 7 5 (1996) 780-785
28. Ayus J.C., Mizani M.R., Achinger S.G., Thadhani R., Go A.S., and Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 16 9 (2005) 2778-2788
29. Santoro A., Mancini E., Bolzani R., et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis 52 3 (2008) 507-518
30. Beerenhout C.H., Luik A.J., Jeuken-Mertens S.G., et al. Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrol Dial Transplant 20 6 (2005) 1155-1163
31. Achinger S.G., and Ayus J.C. The role of daily dialysis in the control of hyperphosphatemia. Kidney Int Suppl 95 (2005) S28-S32
32. Leypoldt J.K. Kinetics of beta2-microglobulin and phosphate during hemodialysis: effects of treatment frequency and duration. Semin Dial 18 5 (2005) 401-408
33. Spalding E.M., Chamney P.W., and Farrington K. Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 61 2 (2002) 655-667
34. Maduell F., Navarro V., Torregrosa E., et al. Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 64 1 (2003) 305-313
35. Locatelli F., Mastrangelo F., Redaelli B., et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int 50 4 (1996) 1293-1302
36. Schiffl H., Lang S.M., Stratakis D., and Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 16 9 (2001) 1863-1869
37. Suda T., Hiroshige K., Ohta T., et al. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 15 3 (2000) 396-401
38. Shinzato T., Miwa M., Nakai S., et al. Alternate repetition of short fore- and backfiltrations reduces convective albumin loss. Kidney Int 50 2 (1996) 432-435
39. Gutierrez O.M., Mannstadt M., Isakova T., et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359 6 (2008) 584-592
40. Urena T.P., Friedlander G., de Vernejoul M.C., Silve C., and Prie D. Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73 1 (2008) 102-107